A mobile health-assisted cardiovascular follow-up after pregnancy complications (MumCare): protocol for a randomized controlled trial.
6 affiliations
- 1Division of Obstetrics and Gynaecology, Oslo University Hospital, Oslo, Norway.
- 2Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.
- 3Department of Technology Systems, University of Oslo, Kjeller, Norway.
- 4Department of Public Health Science and Interdisciplinary Health Science, Faculty of Medicine, University of Oslo, Oslo, Norway.
- 5ProCardio Centre of Innovation, Department of Cardiology, Rikshospitalet, Oslo University Hospital, Oslo, Norway.
- 6Department of Cardiology, Oslo University Hospital, Oslo, Norway.
Abstract
Objective
A history of hypertensive disorders of pregnancy and/or gestational diabetes is associated with increased risk of long-term maternal cardiovascular (CV) disease. Despite recommendations for preventive strategies, few women receive CV follow-up postpartum. We have developed a personalized digital mobile Health companion, the MumCare (Mum's cardiovascular health for life) application, aiming at improving control of modifiable risk factors for CV disease and to bridge hospital and community health services. This paper describes the protocol for a MumCare randomized controlled trial in Norway.Methods
Study participation is offered to women at Oslo University Hospital with a diagnosis of hypertensive disorders of pregnancy and/or gestational diabetes. Following informed consent (either during pregnancy or within 4 weeks postpartum), a block randomization process assigns participants to one of two groups (access to the Mum Care app or not). The app provides educational material, allows women to track modifiable risk factors, and prompts feedback to registered blood pressures. It also prompts the women to book the nationally recommended follow-up at their general practitioner's at 3-4 and 12 months postpartum. The primary study objective is to assess the effect of MumCare application access on 1-year follow-up rate with a general practitioner. Secondary objectives are to assess group differences at 14 months postpartum regarding: 1) satisfaction with the postpartum mHealth-assisted technology, 2) self-management evaluation, general self-efficacy; and at 14-18 months: 3) modifiable risk factors for CV disease (including hypertension, dyslipidemia, blood sugar control, smoking, weight and physical activity), CV non-invasive hemodynamics and CV-related biomarkers.Discussion
This randomized controlled trial tests the effect of a mobile Health-assisted follow-up of modifiable risk factors after pregnancy complications associated with premature CV disease in women. A study limitation is a risk of underrepresentation of recently immigrated women due to the restricted language options offered in the app.Study protocols registration
NCT05835596.
Related
- Impact of Short-Term Fluoride Supplementation in Pregnancy on the Maternal Microbiome, Pregnancy, and Neonatal Outcomes: A Pilot Randomized Controlled Trial
- Pilot Feasibility Study of a Community Health Worker-delivered Tobacco Cessation Intervention During Pregnancy: The Smoke-Free HOPE Randomized Controlled Trial
- PlanetDiet: Sustainable diets and cardiometabolic health, study protocol for a six-month parallel-group randomized controlled trial in middle-aged adults at cardiovascular risk
- Effects of different exercise types on visceral adipose tissue and glycemic parameters in adults with stage 1 cardiovascular-kidney-metabolic syndrome: a systematic review and network meta-analysis of randomized controlled trials
- Controlled postoperative red wine intake versus abstinence in habitual wine drinkers undergoing elective urological surgery (WISE): a translational randomized controlled trial assessing quality of life, surgical outcomes and complications.
BibTeX
@article{staff2026mobile,
title = {{A mobile health-assisted cardiovascular follow-up after pregnancy complications (MumCare): protocol for a randomized controlled trial.}},
author = {Anne Cathrine Staff and Meryam Sugulle and Josef Noll and Miriam K C Sollie-Hoel and Belen Oteiza Aguirre and Bendik S Fiskå and Gunvor Aasbø and Atle Klovning and Mette-Elise Estensen and Åsa Henning Waldum},
journal = {Frontiers in global women's health},
year = {2026},
month = oct,
doi = {10.3389/fgwh.2026.1889953},
url = {https://europepmc.org/article/MED/42947952},
note = {CC BY},
}
RIS
TY - JOUR
TI - A mobile health-assisted cardiovascular follow-up after pregnancy complications (MumCare): protocol for a randomized controlled trial.
AU - Anne Cathrine Staff
AU - Meryam Sugulle
AU - Josef Noll
AU - Miriam K C Sollie-Hoel
AU - Belen Oteiza Aguirre
AU - Bendik S Fiskå
AU - Gunvor Aasbø
AU - Atle Klovning
AU - Mette-Elise Estensen
AU - Åsa Henning Waldum
PY - 2026
DA - 2026/10/13
JO - Frontiers in global women's health
DO - 10.3389/fgwh.2026.1889953
UR - https://europepmc.org/article/MED/42947952
AB - Objective A history of hypertensive disorders of pregnancy and/or gestational diabetes is associated with increased risk of long-term maternal cardiovascular (CV) disease. Despite recommendations for preventive strategies, few women receive CV follow-up postpartum. We have developed a personalized digital mobile Health companion, the MumCare (Mum's cardiovascular health for life) application, aiming at improving control of modifiable risk factors for CV disease and to bridge hospital and community health services. This paper describes the protocol for a MumCare randomized controlled trial in Norway.Methods Study participation is offered to women at Oslo University Hospital with a diagnosis of hypertensive disorders of pregnancy and/or gestational diabetes. Following informed consent (either during pregnancy or within 4 weeks postpartum), a block randomization process assigns participants to one of two groups (access to the Mum Care app or not). The app provides educational material, allows women to track modifiable risk factors, and prompts feedback to registered blood pressures. It also prompts the women to book the nationally recommended follow-up at their general practitioner's at 3-4 and 12 months postpartum. The primary study objective is to assess the effect of MumCare application access on 1-year follow-up rate with a general practitioner. Secondary objectives are to assess group differences at 14 months postpartum regarding: 1) satisfaction with the postpartum mHealth-assisted technology, 2) self-management evaluation, general self-efficacy; and at 14-18 months: 3) modifiable risk factors for CV disease (including hypertension, dyslipidemia, blood sugar control, smoking, weight and physical activity), CV non-invasive hemodynamics and CV-related biomarkers.Discussion This randomized controlled trial tests the effect of a mobile Health-assisted follow-up of modifiable risk factors after pregnancy complications associated with premature CV disease in women. A study limitation is a risk of underrepresentation of recently immigrated women due to the restricted language options offered in the app.Study protocols registration NCT05835596.
SN - 2673-5059
ER -